Google and GlaxoSmithKline fling £540m at bioelectronic meds firm

Mini-robots float round your body and zap your neurons

Google and drug giant GlaxoSmithKline are spending £540m on a new joint venture, Galvani Bioelectronics, in a bid to develop and commercialise bioelectronic medicine.

The partnership between Verily Life Sciences, previously known as Google Life Sciences, and GSK, will boost the British pharmaceutical giant’s efforts in bioelectronic medicine which it has been dabbling in since 2012.

Galvani Bioelectronics will be headquartered in Stevenage, within GSK’s R&D centre, and another branch will be located at Verily’s facilities in south San Francisco.

Bioelectronic medicine is a relatively new scientific field that uses tiny, implantable devices to monitor and control electrical signals within the body.

The nervous system contains billions of neurons – cells that operate on electrical pulses in order to perform a specific function. GSK believes that certain chronic conditions such as arthritis, diabetes and asthma could potentially be treated using bioelectronic medicine.

A bioelectronic device works by targeting a specific area. The goal is to record neural electrical activity, analyse this data in real time, so that the neural signal can be regulated for therapeutic benefits.

Moncef Slaoui, GSK’s chairman of global vaccines, will become chair of the new company's board.

“Bioelectronic medicine’s vision is to employ the latest advances in biology and technology to interpret this electrical conversation and to correct the irregular patterns found in disease states, using miniaturised devices attached to individual nerves. If successful, this approach offers the potential for a new therapeutic modality alongside traditional medicines and vaccines,” Slaoui said.

Verily Life Sciences are also interested in how technology can be applied for medical purposes. It was founded last year and sprung from a Google X project. The aim was to create a contact lens that can be controlled via an electronic chip inside the lens.

The project is being developed by VLS for people with diabetes to measure glucose levels through tears. Current glucose testing methods can be quite painful as it involves pricking the finger to draw blood several times a day.

Other Verily projects use machine learning and algorithms to analyse signals produced from the body in order to identify patterns that lead to new knowledge about the progression of diseases. Analysing the data could diagnose diseases and help make treatments more effective.

Verily are working on a making wearable sensors to gather and analyse biological, physiological, behavioural, and environmental data in order to learn more about multiple sclerosis – a neurological condition where the exact cause remains unknown. ®

Similar topics

Broader topics

Other stories you might like

  • Experts: AI should be recognized as inventors in patent law
    Plus: Police release deepfake of murdered teen in cold case, and more

    In-brief Governments around the world should pass intellectual property laws that grant rights to AI systems, two academics at the University of New South Wales in Australia argued.

    Alexandra George, and Toby Walsh, professors of law and AI, respectively, believe failing to recognize machines as inventors could have long-lasting impacts on economies and societies. 

    "If courts and governments decide that AI-made inventions cannot be patented, the implications could be huge," they wrote in a comment article published in Nature. "Funders and businesses would be less incentivized to pursue useful research using AI inventors when a return on their investment could be limited. Society could miss out on the development of worthwhile and life-saving inventions."

    Continue reading
  • Declassified and released: More secret files on US govt's emergency doomsday powers
    Nuke incoming? Quick break out the plans for rationing, censorship, property seizures, and more

    More papers describing the orders and messages the US President can issue in the event of apocalyptic crises, such as a devastating nuclear attack, have been declassified and released for all to see.

    These government files are part of a larger collection of records that discuss the nature, reach, and use of secret Presidential Emergency Action Documents: these are executive orders, announcements, and statements to Congress that are all ready to sign and send out as soon as a doomsday scenario occurs. PEADs are supposed to give America's commander-in-chief immediate extraordinary powers to overcome extraordinary events.

    PEADs have never been declassified or revealed before. They remain hush-hush, and their exact details are not publicly known.

    Continue reading
  • Stolen university credentials up for sale by Russian crooks, FBI warns
    Forget dark-web souks, thousands of these are already being traded on public bazaars

    Russian crooks are selling network credentials and virtual private network access for a "multitude" of US universities and colleges on criminal marketplaces, according to the FBI.

    According to a warning issued on Thursday, these stolen credentials sell for thousands of dollars on both dark web and public internet forums, and could lead to subsequent cyberattacks against individual employees or the schools themselves.

    "The exposure of usernames and passwords can lead to brute force credential stuffing computer network attacks, whereby attackers attempt logins across various internet sites or exploit them for subsequent cyber attacks as criminal actors take advantage of users recycling the same credentials across multiple accounts, internet sites, and services," the Feds' alert [PDF] said.

    Continue reading

Biting the hand that feeds IT © 1998–2022